{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:16:12Z","timestamp":1792088172206,"version":"4.4.0"},"reference-count":96,"publisher":"The Endocrine Society","issue":"1","funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16\/00264"],"award-info":[{"award-number":["PI16\/00264"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CP15\/00156"],"award-info":[{"award-number":["CP15\/00156"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MINECO","award":["BFU2016-80360-R"],"award-info":[{"award-number":["BFU2016-80360-R"]}]},{"DOI":"10.13039\/501100010566","name":"Consejer\u00eda de Salud, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["BIO-0139"],"award-info":[{"award-number":["BIO-0139"]}],"id":[{"id":"10.13039\/501100010566","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010566","name":"Consejer\u00eda de Salud, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["CTS-1406"],"award-info":[{"award-number":["CTS-1406"]}],"id":[{"id":"10.13039\/501100010566","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1,1]]},"DOI":"10.1210\/jc.2018-01455","type":"journal-article","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T14:02:22Z","timestamp":1538056942000},"page":"57-73","source":"Crossref","is-referenced-by-count":45,"title":["Type 2 Diabetes in Neuroendocrine Tumors: Are Biguanides and Statins Part of the Solution?"],"prefix":"10.1210","volume":"104","author":[{"given":"Aura D","family":"Herrera-Mart\u00ednez","sequence":"first","affiliation":[{"name":"Maimonides Institute for Biomedical Research of Cordoba, C\u00f3rdoba, Spain"},{"name":"Endocrinology and Nutrition Service, Reina Sofia University Hospital, C\u00f3rdoba, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Pedraza-Arevalo","sequence":"additional","affiliation":[{"name":"Maimonides Institute for Biomedical Research of Cordoba, C\u00f3rdoba, Spain"},{"name":"Department of Cell Biology, Physiology, and Immunology, University of C\u00f3rdoba, C\u00f3rdoba, Spain"},{"name":"Reina Sofia University Hospital, C\u00f3rdoba, Spain"},{"name":"CIBER Fisiopatolog\u00eda de la Obesidad y Nutrici\u00f3n, C\u00f3rdoba, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"L-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Maimonides Institute for Biomedical Research of Cordoba, C\u00f3rdoba, Spain"},{"name":"Department of Cell Biology, Physiology, and Immunology, University of C\u00f3rdoba, C\u00f3rdoba, Spain"},{"name":"Reina Sofia University Hospital, C\u00f3rdoba, Spain"},{"name":"CIBER Fisiopatolog\u00eda de la Obesidad y Nutrici\u00f3n, C\u00f3rdoba, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel D","family":"Gahete","sequence":"additional","affiliation":[{"name":"Maimonides Institute for Biomedical Research of Cordoba, C\u00f3rdoba, Spain"},{"name":"Department of Cell Biology, Physiology, and Immunology, University of C\u00f3rdoba, C\u00f3rdoba, Spain"},{"name":"Reina Sofia University Hospital, C\u00f3rdoba, Spain"},{"name":"CIBER Fisiopatolog\u00eda de la Obesidad y Nutrici\u00f3n, C\u00f3rdoba, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda A","family":"G\u00e1lvez-Moreno","sequence":"additional","affiliation":[{"name":"Maimonides Institute for Biomedical Research of Cordoba, C\u00f3rdoba, Spain"},{"name":"Endocrinology and Nutrition Service, Reina Sofia University Hospital, C\u00f3rdoba, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justo P","family":"Casta\u00f1o","sequence":"additional","affiliation":[{"name":"Maimonides Institute for Biomedical Research of Cordoba, C\u00f3rdoba, Spain"},{"name":"Department of Cell Biology, Physiology, and Immunology, University of C\u00f3rdoba, C\u00f3rdoba, Spain"},{"name":"Reina Sofia University Hospital, C\u00f3rdoba, Spain"},{"name":"CIBER Fisiopatolog\u00eda de la Obesidad y Nutrici\u00f3n, C\u00f3rdoba, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7585-1913","authenticated-orcid":false,"given":"Ra\u00fal M","family":"Luque","sequence":"additional","affiliation":[{"name":"Maimonides Institute for Biomedical Research of Cordoba, C\u00f3rdoba, Spain"},{"name":"Department of Cell Biology, Physiology, and Immunology, University of C\u00f3rdoba, C\u00f3rdoba, Spain"},{"name":"Reina Sofia University Hospital, C\u00f3rdoba, Spain"},{"name":"CIBER Fisiopatolog\u00eda de la Obesidad y Nutrici\u00f3n, C\u00f3rdoba, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,9,27]]},"reference":[{"issue":"2","key":"key\n\t\t\t\t2018120107545735700_B1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"key\n\t\t\t\t2018120107545735700_B2","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.7150\/ijbs.7.1003","article-title":"The link between the metabolic syndrome and cancer","volume":"7","author":"Braun","year":"2011","journal-title":"Int J Biol Sci"},{"issue":"2","key":"key\n\t\t\t\t2018120107545735700_B3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2337\/dci15-0013","article-title":"Mechanism of metformin: a tale of two sites","volume":"39","author":"Song","year":"2016","journal-title":"Diabetes Care"},{"issue":"6","key":"key\n\t\t\t\t2018120107545735700_B4","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2337\/diacare.15.6.755","article-title":"Biguanides and NIDDM","volume":"15","author":"Bailey","year":"1992","journal-title":"Diabetes Care"},{"issue":"7503","key":"key\n\t\t\t\t2018120107545735700_B5","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients","volume":"330","author":"Evans","year":"2005","journal-title":"BMJ"},{"issue":"2","key":"key\n\t\t\t\t2018120107545735700_B6","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1053\/j.gastro.2009.04.013","article-title":"Antidiabetic therapies affect risk of pancreatic cancer","volume":"137","author":"Li","year":"2009","journal-title":"Gastroenterology"},{"issue":"1","key":"key\n\t\t\t\t2018120107545735700_B7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2407-11-20","article-title":"Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals","volume":"11","author":"Lee","year":"2011","journal-title":"BMC Cancer"},{"issue":"1","key":"key\n\t\t\t\t2018120107545735700_B8","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1186\/1471-2407-12-410","article-title":"The effect of metformin and thiazolidinedione use on lung cancer in diabetics","volume":"12","author":"Mazzone","year":"2012","journal-title":"BMC Cancer"},{"issue":"3","key":"key\n\t\t\t\t2018120107545735700_B9","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10549-012-2170-x","article-title":"Metformin and breast cancer risk: a meta-analysis and critical literature review","volume":"135","author":"Col","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"19","key":"key\n\t\t\t\t2018120107545735700_B10","doi-asserted-by":"crossref","first-page":"e6888","DOI":"10.1097\/MD.0000000000006888","article-title":"Meta-analysis of studies using metformin as a reducer for liver cancer risk in diabetic patients","volume":"96","author":"Ma","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"key\n\t\t\t\t2018120107545735700_B11","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.1038\/s41598-017-06207-x","article-title":"The effect of metformin on survival of patients with pancreatic cancer: a meta-analysis","volume":"7","author":"Li","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"key\n\t\t\t\t2018120107545735700_B12","doi-asserted-by":"crossref","first-page":"498","DOI":"10.14310\/horm.2002.1517","article-title":"Anticancer effects of metformin on neuroendocrine tumor cells in vitro","volume":"13","author":"Vlotides","year":"2014","journal-title":"Hormones (Athens)"},{"issue":"2","key":"key\n\t\t\t\t2018120107545735700_B13","doi-asserted-by":"crossref","first-page":"e57289","DOI":"10.1371\/journal.pone.0057289","article-title":"Different patterns of Akt and ERK feedback activation in response to rapamycin, active-site mTOR inhibitors and metformin in pancreatic cancer cells","volume":"8","author":"Soares","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"key\n\t\t\t\t2018120107545735700_B14","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J Clin Invest"},{"issue":"6","key":"key\n\t\t\t\t2018120107545735700_B15","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.cmet.2010.04.001","article-title":"Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation","volume":"11","author":"Hawley","year":"2010","journal-title":"Cell Metab"},{"issue":"1","key":"key\n\t\t\t\t2018120107545735700_B16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.14310\/horm.2002.1288","article-title":"Metformin: its emerging role in oncology","volume":"10","author":"Micic","year":"2011","journal-title":"Hormones (Athens)"},{"issue":"13","key":"key\n\t\t\t\t2018120107545735700_B17","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.ejca.2010.06.012","article-title":"Metformin: taking away the candy for cancer","volume":"46","author":"Jalving","year":"2010","journal-title":"Eur J Cancer"},{"issue":"2","key":"key\n\t\t\t\t2018120107545735700_B18","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.tips.2012.11.005","article-title":"Metformin and cancer: from the old medicine cabinet to pharmacological pitfalls and prospects","volume":"34","author":"Emami Riedmaier","year":"2013","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"key\n\t\t\t\t2018120107545735700_B19","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1530\/JME-12-0007","article-title":"Metformin in cancer: translational challenges","volume":"48","author":"Dowling","year":"2012","journal-title":"J Mol Endocrinol"},{"issue":"1","key":"key\n\t\t\t\t2018120107545735700_B20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/CCO.0b013e32834d8155","article-title":"Metformin and cancer therapy","volume":"24","author":"Bost","year":"2012","journal-title":"Curr Opin Oncol"},{"issue":"1","key":"key\n\t\t\t\t2018120107545735700_B21","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12915-014-0082-4","article-title":"Understanding the complex-I-ty of metformin action: limiting mitochondrial respiration to improve cancer therapy","volume":"12","author":"Luengo","year":"2014","journal-title":"BMC Biol"},{"issue":"1","key":"key\n\t\t\t\t2018120107545735700_B22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/pr.111.004994","article-title":"Pharmacological actions of statins: a critical appraisal in the management of cancer","volume":"64","author":"Gazzerro","year":"2012","journal-title":"Pharmacol Rev"},{"issue":"8","key":"key\n\t\t\t\t2018120107545735700_B23","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1124\/mi.2.8.478","article-title":"Toward a role for statins in immunomodulation","volume":"2","author":"Mach","year":"2002","journal-title":"Mol Interv"},{"issue":"3","key":"key\n\t\t\t\t2018120107545735700_B24","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s11883-000-0022-3","article-title":"Pleiotropic effects of statins","volume":"2","author":"Farmer","year":"2000","journal-title":"Curr Atheroscler Rep"},{"issue":"3","key":"key\n\t\t\t\t2018120107545735700_B25","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3109\/07853890008998823","article-title":"Non-lipid-related effects of statins","volume":"32","author":"Bellosta","year":"2000","journal-title":"Ann Med"},{"issue":"1","key":"key\n\t\t\t\t2018120107545735700_B26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1517\/14656566.2.1.153","article-title":"Pharmacology and clinical experience with simvastatin","volume":"2","author":"Hess","year":"2001","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"key\n\t\t\t\t2018120107545735700_B27","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/ijc.20522","article-title":"Long-term activation of SAPK\/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance","volume":"112","author":"Brozovic","year":"2004","journal-title":"Int J Cancer"},{"issue":"2","key":"key\n\t\t\t\t2018120107545735700_B28","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.canlet.2006.10.009","article-title":"Simvastatin induces apoptosis in human breast cancer cells: p53 and estrogen receptor independent pathway requiring signalling through JNK","volume":"250","author":"Koyuturk","year":"2007","journal-title":"Cancer Lett"},{"issue":"8","key":"key\n\t\t\t\t2018120107545735700_B29","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/carcin\/22.8.1139","article-title":"Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study","volume":"22","author":"Denoyelle","year":"2001","journal-title":"Carcinogenesis"},{"issue":"2","key":"key\n\t\t\t\t2018120107545735700_B30","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10549-013-2473-6","article-title":"Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial","volume":"138","author":"Bjarnadottir","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"key\n\t\t\t\t2018120107545735700_B31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10549-009-0507-x","article-title":"Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer","volume":"119","author":"Garwood","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"key\n\t\t\t\t2018120107545735700_B32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.5114\/ada.2016.61601","article-title":"Anti-proliferative and cytotoxic activity of rosuvastatin against melanoma cells","volume":"33","author":"Maj","year":"2016","journal-title":"Postepy Dermatol Alergol"},{"issue":"1","key":"key\n\t\t\t\t2018120107545735700_B33","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3892\/ol.2016.4569","article-title":"Statin induces apoptosis of human colon cancer cells and downregulation of insulin-like growth factor 1 receptor via proapoptotic ERK activation","volume":"12","author":"Jang","year":"2016","journal-title":"Oncol Lett"},{"key":"key\n\t\t\t\t2018120107545735700_B34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijcard.2015.01.005","article-title":"Treatment of pheochromocytoma blockade of MAPK pathway inhibition in the NF-\u03baB pathway and bFGF - effect of statins on pheochromocytoma patients","volume":"182","author":"Hu","year":"2015","journal-title":"Int J Cardiol"},{"issue":"5","key":"key\n\t\t\t\t2018120107545735700_B35","doi-asserted-by":"crossref","first-page":"e97712","DOI":"10.1371\/journal.pone.0097712","article-title":"Anti-cancer potential of MAPK pathway inhibition in paragangliomas-effect of different statins on mouse pheochromocytoma cells","volume":"9","author":"Fliedner","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"key\n\t\t\t\t2018120107545735700_B36","first-page":"596","article-title":"Establishment of a carcinoembryonic antigen-producing cell line from human pancreatic carcinoma","volume":"71","author":"Kaku","year":"1980","journal-title":"Gan"},{"issue":"12","key":"key\n\t\t\t\t2018120107545735700_B37","first-page":"3691","article-title":"A somatostatin-secreting cell line established from a human pancreatic islet cell carcinoma (somatostatinoma): release experiment and immunohistochemical study","volume":"50","author":"Iguchi","year":"1990","journal-title":"Cancer Res"},{"issue":"2","key":"key\n\t\t\t\t2018120107545735700_B38","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0016-5085(91)90004-5","article-title":"Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth","volume":"101","author":"Evers","year":"1991","journal-title":"Gastroenterology"},{"issue":"3","key":"key\n\t\t\t\t2018120107545735700_B39","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1530\/ERC-17-0445","article-title":"The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines","volume":"25","author":"Hofving","year":"2018","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"key\n\t\t\t\t2018120107545735700_B40","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12943-017-0713-9","article-title":"The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness","volume":"16","author":"Hormaechea-Agulla","year":"2017","journal-title":"Mol Cancer"},{"issue":"1","key":"key\n\t\t\t\t2018120107545735700_B41","doi-asserted-by":"crossref","first-page":"8714","DOI":"10.1038\/srep08714","article-title":"In1-ghrelin splicing variant is overexpressed in pituitary adenomas and increases their aggressive features","volume":"5","author":"Ib\u00e1\u00f1ez-Costa","year":"2015","journal-title":"Sci Rep"},{"issue":"7","key":"key\n\t\t\t\t2018120107545735700_B42","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1158\/1541-7786.MCR-16-0493","article-title":"Metformin reduces prostate tumor growth, in a diet-dependent manner, by modulating multiple signaling pathways","volume":"15","author":"Sarmento-Cabral","year":"2017","journal-title":"Mol Cancer Res"},{"issue":"7","key":"key\n\t\t\t\t2018120107545735700_B43","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1210\/jc.2008-2564","article-title":"Identification and characterization of two novel truncated but functional isoforms of the somatostatin receptor subtype 5 differentially present in pituitary tumors","volume":"94","author":"Dur\u00e1n-Prado","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"key\n\t\t\t\t2018120107545735700_B44","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1210\/jc.2006-0235","article-title":"Ghrelin is produced by and directly activates corticotrope cells from adrenocorticotropin-secreting adenomas","volume":"91","author":"Mart\u00ednez-Fuentes","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key\n\t\t\t\t2018120107545735700_B45","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s12020-017-1482-3","article-title":"Clinical and functional implication of the components of somatostatin system in gastroenteropancreatic neuroendocrine tumors","volume":"59","author":"Herrera-Mart\u00ednez","year":"2018","journal-title":"Endocrine"},{"key":"key\n\t\t\t\t2018120107545735700_B46","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.lungcan.2017.05.006","article-title":"The components of somatostatin and ghrelin systems are altered in neuroendocrine lung carcinoids and associated to clinical-histological features","volume":"109","author":"Herrera-Mart\u00ednez","year":"2017","journal-title":"Lung Cancer"},{"issue":"1","key":"key\n\t\t\t\t2018120107545735700_B47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.canlet.2016.09.022","article-title":"Ghrelin O-acyltransferase (GOAT) enzyme is overexpressed in prostate cancer, and its levels are associated with patient\u2019s metabolic status: Potential value as a non-invasive biomarker","volume":"383","author":"Hormaechea-Agulla","year":"2016","journal-title":"Cancer Lett"},{"issue":"6","key":"key\n\t\t\t\t2018120107545735700_B48","doi-asserted-by":"crossref","first-page":"6593","DOI":"10.18632\/oncotarget.6565","article-title":"Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors","volume":"7","author":"Sampedro-N\u00fa\u00f1ez","year":"2016","journal-title":"Oncotarget"},{"issue":"7","key":"key\n\t\t\t\t2018120107545735700_B49","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1210\/en.2013-1261","article-title":"Insulin and IGF-I inhibit GH synthesis and release in vitro and in vivo by separate mechanisms","volume":"154","author":"Gahete","year":"2013","journal-title":"Endocrinology"},{"issue":"9","key":"key\n\t\t\t\t2018120107545735700_B50","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1111\/jcmm.13109","article-title":"Obesity and metabolic dysfunction severely influence prostate cell function: role of insulin and IGF1","volume":"21","author":"L-L\u00f3pez","year":"2017","journal-title":"J Cell Mol Med"},{"issue":"12","key":"key\n\t\t\t\t2018120107545735700_B51","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1210\/en.2011-1447","article-title":"Elevated GH\/IGF-I, due to somatotrope-specific loss of both IGF-I and insulin receptors, alters glucose homeostasis and insulin sensitivity in a diet-dependent manner","volume":"152","author":"Gahete","year":"2011","journal-title":"Endocrinology"},{"issue":"16","key":"key\n\t\t\t\t2018120107545735700_B52","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1038\/onc.2011.389","article-title":"The new truncated somatostatin receptor variant sst5TMD4 is associated to poor prognosis in breast cancer and increases malignancy in MCF-7 cells","volume":"31","author":"Dur\u00e1n-Prado","year":"2012","journal-title":"Oncogene"},{"issue":"7","key":"key\n\t\t\t\t2018120107545735700_B53","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"issue":"29","key":"key\n\t\t\t\t2018120107545735700_B54","doi-asserted-by":"crossref","first-page":"26960","DOI":"10.18632\/oncotarget.4745","article-title":"Differential expression and tumorigenic function of neurotensin receptor 1 in neuroendocrine tumor cells","volume":"6","author":"Kim","year":"2015","journal-title":"Oncotarget"},{"issue":"5","key":"key\n\t\t\t\t2018120107545735700_B55","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1053\/j.gastro.2008.05.047","article-title":"Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors","volume":"135","author":"Metz","year":"2008","journal-title":"Gastroenterology"},{"issue":"s","key":"key\n\t\t\t\t2018120107545735700_B56","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1007\/s00259-011-2039-y","article-title":"Lutetium-labelled peptides for therapy of neuroendocrine tumours","volume":"39","author":"Kam","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"key\n\t\t\t\t2018120107545735700_B57","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa1009290","article-title":"Everolimus for advanced pancreatic neuroendocrine tumors","volume":"364","author":"Yao","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"key\n\t\t\t\t2018120107545735700_B58","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJMoa1003825","article-title":"Sunitinib malate for the treatment of pancreatic neuroendocrine tumors","volume":"364","author":"Raymond","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"key\n\t\t\t\t2018120107545735700_B59","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000100057","article-title":"The novel mTOR inhibitor RAD001 (everolimus) induces antiproliferative effects in human pancreatic neuroendocrine tumor cells","volume":"85","author":"Zitzmann","year":"2007","journal-title":"Neuroendocrinology"},{"issue":"3","key":"key\n\t\t\t\t2018120107545735700_B60","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ctrv.2013.08.007","article-title":"A systematic review of non-surgical treatments for pancreatic neuroendocrine tumours","volume":"40","author":"Valle","year":"2014","journal-title":"Cancer Treat Rev"},{"issue":"19","key":"key\n\t\t\t\t2018120107545735700_B61","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1001\/jama.2015.4260","article-title":"Prevalence of the metabolic syndrome in the United States, 2003-2012","volume":"313","author":"Aguilar","year":"2015","journal-title":"JAMA"},{"issue":"4","key":"key\n\t\t\t\t2018120107545735700_B62","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3322\/caac.20078","article-title":"Diabetes and cancer: a consensus report","volume":"60","author":"Giovannucci","year":"2010","journal-title":"CA Cancer J Clin"},{"issue":"14","key":"key\n\t\t\t\t2018120107545735700_B63","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.7150\/jca.16110","article-title":"The impact of diabetes on the risk of prostate cancer development according to body mass index: A 10-year nationwide cohort study","volume":"7","author":"Choi","year":"2016","journal-title":"J Cancer"},{"issue":"1","key":"key\n\t\t\t\t2018120107545735700_B64","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1200\/JCO.2009.24.2669","article-title":"Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial","volume":"28","author":"Yao","year":"2010","journal-title":"J Clin Oncol"},{"issue":"7","key":"key\n\t\t\t\t2018120107545735700_B65","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/annonc\/mdx193","article-title":"Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 study","volume":"28","author":"Pavel","year":"2017","journal-title":"Ann Oncol"},{"issue":"2","key":"key\n\t\t\t\t2018120107545735700_B66","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1007\/s12032-011-9846-7","article-title":"Metformin and cancer: new applications for an old drug","volume":"29","author":"Kourelis","year":"2012","journal-title":"Med Oncol"},{"issue":"1","key":"key\n\t\t\t\t2018120107545735700_B67","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/bjc.2016.149","article-title":"Statin use and all-cancer survival: prospective results from the Women\u2019s Health Initiative","volume":"115","author":"Wang","year":"2016","journal-title":"Br J Cancer"},{"issue":"3","key":"key\n\t\t\t\t2018120107545735700_B68","doi-asserted-by":"crossref","first-page":"223","DOI":"10.7150\/ijms.10656","article-title":"Association between statin use and cancer: data mining of a spontaneous reporting database and a claims database","volume":"12","author":"Fujimoto","year":"2015","journal-title":"Int J Med Sci"},{"issue":"4","key":"key\n\t\t\t\t2018120107545735700_B69","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1210\/er.2010-0020","article-title":"Genetic syndromes of severe insulin resistance","volume":"32","author":"Semple","year":"2011","journal-title":"Endocr Rev"},{"issue":"5","key":"key\n\t\t\t\t2018120107545735700_B70","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.2353\/ajpath.2006.051090","article-title":"The metabolic syndrome: a high-risk state for cancer","volume":"169","author":"Cowey","year":"2006","journal-title":"Am J Pathol"},{"issue":"6","key":"key\n\t\t\t\t2018120107545735700_B71","first-page":"57","article-title":"Metformin in cancer prevention and therapy","volume":"2","author":"Kasznicki","year":"2014","journal-title":"Ann Transl Med"},{"issue":"9","key":"key\n\t\t\t\t2018120107545735700_B72","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1158\/1940-6207.CAPR-13-0424","article-title":"Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders","volume":"7","author":"Gandini","year":"2014","journal-title":"Cancer Prev Res (Phila)"},{"issue":"10","key":"key\n\t\t\t\t2018120107545735700_B73","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.2217\/fon-2015-0077","article-title":"Metformin with everolimus and octreotide in pancreatic neuroendocrine tumor patients with diabetes","volume":"12","author":"Pusceddu","year":"2016","journal-title":"Future Oncol"},{"issue":"6","key":"key\n\t\t\t\t2018120107545735700_B74","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/jdi.12328","article-title":"New mechanisms of metformin action: focusing on mitochondria and the gut","volume":"6","author":"Hur","year":"2015","journal-title":"J Diabetes Investig"},{"issue":"1","key":"key\n\t\t\t\t2018120107545735700_B75","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1677\/ERC-07-0202","article-title":"Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumors","volume":"15","author":"Moreno","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"key\n\t\t\t\t2018120107545735700_B76","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3389\/fendo.2018.00146","article-title":"Octreotide does not inhibit proliferation in five neuroendocrine tumor cell lines","volume":"9","author":"Exner","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"key\n\t\t\t\t2018120107545735700_B77","first-page":"67","article-title":"[Inhibiting effect of phenformin (phenethyl biguanide) on the growth of Ehrlich carcinoma]","volume":"27","author":"Shikhman","year":"1981","journal-title":"Vopr Onkol"},{"issue":"21","key":"key\n\t\t\t\t2018120107545735700_B78","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1158\/0008-5472.CAN-06-1500","article-title":"Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells","volume":"66","author":"Zakikhani","year":"2006","journal-title":"Cancer Res"},{"issue":"13","key":"key\n\t\t\t\t2018120107545735700_B79","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.4161\/cc.8.13.8814","article-title":"Metformin induces unique biological and molecular responses in triple negative breast cancer cells","volume":"8","author":"Liu","year":"2009","journal-title":"Cell Cycle"},{"issue":"4","key":"key\n\t\t\t\t2018120107545735700_B80","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<770::AID-CNCR6>3.0.CO;2-0","article-title":"Treatment of carcinoid syndrome: a prospective crossover evaluation of lanreotide versus octreotide in terms of efficacy, patient acceptability, and tolerance","volume":"88","author":"O\u2019Toole","year":"2000","journal-title":"Cancer"},{"issue":"6","key":"key\n\t\t\t\t2018120107545735700_B81","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1159\/000444280","article-title":"Effects of somatostatin analogs and dopamine agonists on insulin-like growth factor 2-induced insulin receptor isoform a activation by gastroenteropancreatic neuroendocrine tumor cells","volume":"103","author":"van Adrichem","year":"2016","journal-title":"Neuroendocrinology"},{"issue":"23","key":"key\n\t\t\t\t2018120107545735700_B82","doi-asserted-by":"crossref","first-page":"19619","DOI":"10.18632\/oncotarget.4316","article-title":"In1-ghrelin, a splice variant of ghrelin gene, is associated with the evolution and aggressiveness of human neuroendocrine tumors: Evidence from clinical, cellular and molecular parameters","volume":"6","author":"Luque","year":"2015","journal-title":"Oncotarget"},{"issue":"3","key":"key\n\t\t\t\t2018120107545735700_B83","doi-asserted-by":"crossref","first-page":"R153","DOI":"10.1530\/ERC-13-0125","article-title":"Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature","volume":"21","author":"Fraenkel","year":"2014","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"key\n\t\t\t\t2018120107545735700_B84","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12967-015-0486-0","article-title":"Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial","volume":"13","author":"Feldt","year":"2015","journal-title":"J Transl Med"},{"issue":"4","key":"key\n\t\t\t\t2018120107545735700_B85","doi-asserted-by":"crossref","first-page":"411","DOI":"10.59566\/IJBS.2009.5411","article-title":"Statins inhibit the proliferation and induce cell death of human papilloma virus positive and negative cervical cancer cells","volume":"5","author":"Crescencio","year":"2009","journal-title":"Int J Biomed Sci"},{"issue":"1","key":"key\n\t\t\t\t2018120107545735700_B86","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/2050-7771-1-33","article-title":"Statins inhibit proliferation and cytotoxicity of a human leukemic natural killer cell line","volume":"1","author":"Crosbie","year":"2013","journal-title":"Biomark Res"},{"issue":"3","key":"key\n\t\t\t\t2018120107545735700_B87","first-page":"561","article-title":"Statins induce apoptosis and inhibit proliferation in cholangiocarcinoma cells","volume":"39","author":"Kamigaki","year":"2011","journal-title":"Int J Oncol"},{"issue":"2","key":"key\n\t\t\t\t2018120107545735700_B88","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.prnil.2016.02.003","article-title":"Low-density lipoprotein receptors play an important role in the inhibition of prostate cancer cell proliferation by statins","volume":"4","author":"Furuya","year":"2016","journal-title":"Prostate Int"},{"issue":"3","key":"key\n\t\t\t\t2018120107545735700_B89","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11864-014-0294-4","article-title":"Targeting the mTOR signaling pathway in neuroendocrine tumors","volume":"15","author":"Chan","year":"2014","journal-title":"Curr Treat Options Oncol"},{"issue":"9","key":"key\n\t\t\t\t2018120107545735700_B90","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1158\/1940-6207.CAPR-10-0055","article-title":"Metformin prevents tobacco carcinogen--induced lung tumorigenesis","volume":"3","author":"Memmott","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"issue":"6","key":"key\n\t\t\t\t2018120107545735700_B91","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2184.2012.00846.x","article-title":"Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non-small lung cancer cells","volume":"45","author":"Pelaia","year":"2012","journal-title":"Cell Prolif"},{"issue":"1","key":"key\n\t\t\t\t2018120107545735700_B92","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12885-016-2343-9","article-title":"Heme oxygenase is not involved in the anti-proliferative effects of statins on pancreatic cancer cells","volume":"16","author":"Vanova","year":"2016","journal-title":"BMC Cancer"},{"issue":"5-6","key":"key\n\t\t\t\t2018120107545735700_B93","first-page":"225","article-title":"Statins cause profound effects on gene expression in human cancer cells in vitro: the role of membrane microdomains","volume":"15","author":"Garnett","year":"2012","journal-title":"Gene Expr"},{"issue":"2","key":"key\n\t\t\t\t2018120107545735700_B94","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/0897190015627255","article-title":"Synergistic benefit of statin and metformin in gastrointestinal malignancies","volume":"30","author":"Nimako","year":"2017","journal-title":"J Pharm Pract"},{"issue":"1","key":"key\n\t\t\t\t2018120107545735700_B95","doi-asserted-by":"crossref","first-page":"e0191805","DOI":"10.1371\/journal.pone.0191805","article-title":"Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy","volume":"13","author":"Del Campo","year":"2018","journal-title":"PLoS One"},{"issue":"10","key":"key\n\t\t\t\t2018120107545735700_B96","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1158\/1535-7163.MCT-14-0451","article-title":"Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer","volume":"13","author":"Babcook","year":"2014","journal-title":"Mol Cancer Ther"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/104\/1\/57\/26931229\/jc.2018-01455.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T19:39:13Z","timestamp":1755718753000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/104\/1\/57\/5107298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,27]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,9,27]]},"published-print":{"date-parts":[[2019,1,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2018-01455","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,1]]},"published":{"date-parts":[[2018,9,27]]}}}